You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 14, 2025

Drug Price Trends for STOOL SOFTENER-STIM LAX TABLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for STOOL SOFTENER-STIM LAX TABLET

Average Pharmacy Cost for STOOL SOFTENER-STIM LAX TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
STOOL SOFTENER-STIM LAX TABLET 70000-0526-01 0.03172 EACH 2025-06-18
STOOL SOFTENER-STIM LAX TABLET 70000-0526-01 0.03180 EACH 2025-05-21
STOOL SOFTENER-STIM LAX TABLET 70000-0526-01 0.03085 EACH 2025-04-23
STOOL SOFTENER-STIM LAX TABLET 70000-0526-01 0.03041 EACH 2025-03-19
STOOL SOFTENER-STIM LAX TABLET 70000-0526-01 0.02887 EACH 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Stool Softener-Stimulant Laxative Tablets

Last updated: December 31, 2024

Introduction to Stool Softener-Stimulant Laxative Tablets

Stool softener-stimulant laxative tablets are a type of medication designed to provide relief from constipation by both softening the stool and stimulating bowel movements. These tablets typically contain ingredients like sennosides and docusate sodium, which work synergistically to draw water into the gut and soften the stool, making it easier to pass[2].

Market Dynamics

Increasing Prevalence of Gastrointestinal Disorders

The demand for stool softener-stimulant laxative tablets is significantly driven by the rising prevalence of gastrointestinal disorders such as constipation and irritable bowel syndrome (IBS). As more people adopt sedentary lifestyles and consume diets low in fiber, the incidence of constipation increases, leading to a higher demand for effective laxative solutions[1].

Expanding Geriatric Population

The global population is aging, and this demographic shift is a key driver for the laxative market. Older adults are more prone to constipation due to reduced physical activity, changes in diet, and the use of medications that can cause constipation. This expanding geriatric population is expected to fuel the growth of the laxative market, including stool softener-stimulant laxative tablets[1][4].

Regional Market Trends

North America

North America is anticipated to dominate the global laxative market, including the segment for stool softener-stimulant laxative tablets. The region's growth is driven by high healthcare spending, the presence of major pharmaceutical companies, and the adoption of advanced technologies. Additionally, the increasing prevalence of constipation in the pediatric population and opioid-induced constipation are significant factors contributing to market growth in this region[1][4].

Asia-Pacific

The Asia-Pacific region is expected to be the fastest-growing market for laxatives, including stool softener-stimulant laxative tablets. This growth is attributed to increasing investments in research and development, the expansion of healthcare infrastructure, and the rise of generic drug manufacturers in countries like India, Australia, and New Zealand[1][5].

Europe

Europe is also a significant market, driven by the rising incidence of chronic constipation and other bowel disorders. Therapeutic guidelines in European countries often recommend osmotic laxatives as the first-line treatment for chronic idiopathic constipation (CIC), but stool softener-stimulant laxative tablets are also gaining traction as effective alternatives[4].

Market Size and Growth Projections

Global Market Size

The global laxative market, which includes stool softener-stimulant laxative tablets, is projected to grow significantly. By 2031, the market is expected to reach USD 11.26 billion from USD 6.91 billion in 2023, growing at a CAGR of 6.3% during the forecast period[1].

Segment-Specific Growth

Bulk-forming laxatives are expected to capture the maximum market share, but stimulant laxatives, which include stool softener-stimulant combinations, are poised to expand the fastest at a CAGR of 6.0%. This rapid growth is due to their immediate effectiveness and the preference for over-the-counter medications for constipation treatment[3].

Price Projections

Factors Influencing Pricing

The pricing of stool softener-stimulant laxative tablets is influenced by several factors, including production costs, regulatory approvals, market competition, and consumer demand. As the market grows, economies of scale and increased competition among manufacturers are likely to stabilize or reduce prices.

Regional Pricing Trends

In North America, the prices of laxative products, including stool softener-stimulant laxative tablets, are generally higher due to high healthcare spending and the presence of major pharmaceutical companies. In contrast, the Asia-Pacific region, particularly countries like India, may offer more competitive pricing due to the presence of generic drug manufacturers[1][5].

Competitive Landscape

The global stool softener market, including the segment for stool softener-stimulant laxative tablets, is fairly fragmented with many large and medium-sized companies. Major players are engaging in strategies such as mergers and acquisitions, strategic agreements, and the development of more effective medications to maintain market share and drive growth[4].

Consumer Preferences and Trends

Ease of Ingestion

Consumers increasingly prefer laxatives that are easy to ingest and provide gradual improvement of symptoms. Bulk-forming laxatives and stool softener-stimulant combinations are popular due to their ease of use and effectiveness in preventing side effects like explosive diarrhea[3].

Over-the-Counter (OTC) Medications

There is a rising preference for treating constipation using OTC medications. Stool softener-stimulant laxative tablets, being available without a prescription, are gaining popularity as a convenient and accessible treatment option[4].

Key Statistics

  • Global Prevalence of Constipation: Functional constipation affects over 29% of the global population, according to the National Center for Biotechnology Information (NCBI)[4].
  • Opioid-Induced Constipation: In the U.S., 4% to 5% of the population regularly consumes opioid drugs, with 40% to 80% suffering from opioid-induced constipation, as estimated by the American Gastroenterological Association Institute[4].
  • Pediatric Constipation: Over 3% of all pediatrician visits and 25% of pediatric gastroenterologist visits are associated with constipation-related issues in North America[4].

Key Takeaways

  • The global laxative market, including stool softener-stimulant laxative tablets, is driven by increasing gastrointestinal disorders and an expanding geriatric population.
  • North America and the Asia-Pacific region are key markets, with the latter expected to grow the fastest.
  • Consumer preference for easy-to-ingest and effective OTC medications is driving the demand for stool softener-stimulant laxative tablets.
  • The market is expected to grow at a CAGR of 6.3% from 2023 to 2031, reaching USD 11.26 billion.

FAQs

What are the main ingredients in stool softener-stimulant laxative tablets?

Stool softener-stimulant laxative tablets typically contain ingredients like sennosides and docusate sodium, which work together to draw water into the gut and soften the stool.

Why is the demand for stool softener-stimulant laxative tablets increasing?

The demand is increasing due to the rising prevalence of gastrointestinal disorders such as constipation and irritable bowel syndrome, as well as the expanding geriatric population.

Which region is expected to dominate the global laxative market?

North America is expected to dominate the global laxative market in terms of both market share and revenue.

What is the projected CAGR for the global laxative market?

The global laxative market is expected to grow at a CAGR of 6.3% from 2023 to 2031.

Are stool softener-stimulant laxative tablets available over-the-counter?

Yes, stool softener-stimulant laxative tablets are generally available without a prescription, making them a convenient OTC treatment option for constipation.

Sources

  1. Databridge Market Research: Global Laxative Market – Industry Trends and Forecast to 2031.
  2. Target: Laxative With Stool Softener Tablets - 100ct - Up&up.
  3. Fact.MR: Constipation Laxative Market Size & Industry Share by 2030.
  4. Emergen Research: Stool Softener Industry Trend, Forecast [2021-2030] | Market Report.
  5. Market Data Forecast: Laxative Market Size, Share & Growth Report, 2032.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.